During the past decade, Shinkomonji hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shinkomonji hospital" are "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials), "Metapneumovirus" (1 trials), "Respiratory Syncytial Virus" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "Shinkomonji hospital" in a lesser frequency.

Most popular intervention types in "Shinkomonji hospital" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ExPEC9V" (1 trials), "JNJ-53718678 500 mg" (1 trials), "JNJ-53718678 80 mg" (1 trials) and "Lumicitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shinkomonji hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Shinkomonji hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Shinkomonji hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shinkomonji hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".